Douglas Bias, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W Main St, Troy, OH 45373 Phone: 937-980-7010 |
Lisa Michelle Ward, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3130 N Dixie Hwy, Troy, OH 45373 Phone: 937-440-4600 Fax: 937-339-4056 |
Richard W Frantz, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3130 N Dixie Hwy, Troy, OH 45373 Phone: 937-440-4600 Fax: 937-339-4056 |
Timothy Allen Morton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3130 N County Road 25a, Troy, OH 45373 Phone: 937-440-4000 |
Patrick A Vaglienti, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3130 N Dixie Hwy, Troy, OH 45373 Phone: 937-440-4600 Fax: 937-339-4056 |
Dr. Ketan D Merchant, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3130 N Dixie Hwy, Troy, OH 45373 Phone: 937-440-4600 Fax: 937-339-4056 |
Dr. Jon Kristian Riggs, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 600 W Main St, Troy, OH 45373 Phone: 937-980-7010 |
Julia A Dicicco, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3130 N Dixie Hwy, Troy, OH 45373 Phone: 937-440-4600 Fax: 937-339-4056 |
News Archive
Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers at University of California San Diego School of Medicine and Moores Cancer Center discovered that a cell surface molecule known as CD98 promotes AML.
According to results of a survey presented at the 72nd Annual Scientific Meeting of the American College of Gastroenterology, nighttime acid reflux, along with some of the less typical manifestations or symptoms of gastroesophageal reflux disease (GERD), is associated with significant sleep impairment.
4SC AG, a drug discovery and development company, today announced the start of dosing in a First-in-Man Phase I study in healthy volunteers evaluating 4SC-203, a novel multi-target kinase inhibitor, with particular specificity against selected kinases, including FMS-like tyrosine kinase 3 (FLT3), FLT3 mutants and vascular endothelial growth factor receptors (VEGF-R).
Bristol-Myers Squibb Company today announced its Board of Directors has authorized the repurchase of up to $3 billion of its common stock.
Many Americans suffer from bipolar disorder and their treatment often includes myriad medications. But what if there is another way to cope with the illness that comes from within? In his revolutionary new guidebook, "Living Out of Darkness: A personal journey of embracing the bipolar opportunity" (published by AuthorHouse), George Denslow - who was diagnosed bipolar at age 17 - presents a comprehensive, in-depth look at how to manage bipolar symptoms using a technique he calls "unmedicated spiritual engagement."
› Verified 6 days ago